Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): The TRY study

Liver Transplantation

Volumn 15, Issue 9, 2009, Pages 1083-1091

  Karie Guigues, Svetlana ^a   Janus, Nicolas ^a   Saliba, Faouzi ^b   Dumortier, Jerome ^c   Duvoux, Christophe ^d   Calmus, Yvon ^e   Lorho, Richard ^f   Deray, Gilbert ^a   Launay Vacher, Vincent ^a   Pageaux, Georges Philippe ^g  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e Service de Chirurgie Hôpital Cochin ^*  (France)

^f PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^g HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG EXPOSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTRAHEPATIC CHOLESTASIS; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; CALCINEURIN; CYCLOSPORINE; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LINEAR MODELS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STEROIDS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70350530298     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21803     Document Type: Article

References (35)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-S266.
2. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-2100. (Pubitemid 41623371)
3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
4. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470. (Pubitemid 29135798)
5. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-254. (Pubitemid 46768608)
6. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004;10:301-309. (Pubitemid 38240131)
7. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-940. (Pubitemid 37064766)
8. O'Riordan A, Wong V, McCormick PA, Hegarty JE, Watson AJ. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant 2006;21:2630-2636. (Pubitemid 44644543)
9. Moreno JM, Cuervas-Mons V, Rubio E, Pons F, Herreros de TA, Turrión VS, Millán I. Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality. Transplant Proc 2003;35:1907-1908. (Pubitemid 37093759)
10. Fisher NC, Nightingale PG, Gunson BK, Lipkin GW, Neuberger JM. Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation 1998;66:59-66. (Pubitemid 28341169)
11. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000;69:781-789. (Pubitemid 30174097)
12. Slapak GI, Saxena R, Portmann B, Gane E, Devlin J, Calne R, Williams R. Graft and systemic disease in long-term survivors of liver transplantation. Hepatology 1997;25:195-202. (Pubitemid 27015010)
13. Cohen AJ, Stegall MD, Rosen CB, Wiesner RH, Leung N, Kremers WK, Zein NN. Chronic renal dysfunction late after liver transplantation. Liver Transpl 2002;8:916-921. (Pubitemid 35154021)
14. Nutritional Anemias: Reports of a WHO Scientific Group. Geneva, Switzerland: World Health Organization; 1968.
15. Levey AS, Greene T, Kusek JW. A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol 2000;11:0828.
16. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470. (Pubitemid 32119037)
17. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005;42(suppl):S100-S107. (Pubitemid 40364609)
18. Cabezuelo JB, Ramírez P, Ríos A, Acosta F, Torres D, Sansano T, et al. Risk factors of acute renal failure after liver transplantation. Kidney Int 2006;69:1073-1080. (Pubitemid 43372183)
19. Cocchetto DM, Tschanz C, Bjornsson TD. Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. Ther Drug Monit 1983;5:161-168.
20. Gecelter GR, Comer GM. Nutritional support during liver failure. Crit Care Clin 1995;11:675-683.
21. Skluzacek PA, Szewc RG, Nolan CR III, Riley DJ, Lee S, Pergola PE. Prediction of GFR in liver transplant candidates. Am J Kidney Dis 2003;42:1169-1176. (Pubitemid 37486760)
22. Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994;154:201-205. (Pubitemid 24032194)
23. Gonwa TA, Mai ML, Klintmalm GB. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:2563-2565; author reply 2563-2565.
24. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 2001;72:1934-1939.
25. Wilkinson A, Pham PT. Kidney dysfunction in the recipients of liver transplants. Liver Transpl 2005;11:S47-S51. (Pubitemid 43072615)
26. Iwatsuki S, Esquivel CO, Klintmalm GB, Gordon RD, Shaw BW Jr, Starzl TE. Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc 1985;17:191-195.
27. Farkas SA, Schnitzbauer AA, Kirchner G, Obed A, Banas B, Schlitt HJ. Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int 2009;22:49-60.
28. Pageaux GP, Rostaing L, Calmus Y, Duvoux C, Vanlemmens C, Hardgwissen J, et al. Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Liver Transpl 2006;12:1755-1760. (Pubitemid 44920019)
29. Jain A, Vekatramanan R, Eghtesad B, Gadomski M, Mohanka R, Marcos A, Fung J. Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation. Transplantation 2005;80:859-864. (Pubitemid 41443771)
30. Créput C, Blandin F, Deroure B, Roche B, Saliba F, Charpentier B, et al. Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation. Liver Transpl 2007;13:1004-1010. (Pubitemid 47163193)
31. Romero F, Rodriguez-Iturbe B, Parra G, Gonzalez L, Herrera-Acosta J, Tapia E. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 1999;55:945-955. (Pubitemid 29100706)
32. Morath C, Schwenger V, Beimler J, Mehrabi A, Schmidt J, Zeier M, Muranyi W. Antifibrotic actions of mycophenolic acid. Clin Transplant 2006;20(suppl 17):25-29.
33. Asfandiyar S, Abouljoud M, Kim D, Brown K, Yoshida A, Arenas J, et al. Influence of hepatitis C on renal function after liver transplantation. Transplant Proc 2006;38:3643-3645. (Pubitemid 44908541)
34. Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Dig Liver Dis 2009;41:350-356.
35. Sanchez EQ, Gonwa TA, Levy MF, Goldstein RM, Mai ML, Hays SR, et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 2004;78:1048-1054.